Business Overview
Ontada
Offering real-world data and evidence, provider education and point-of-care technology.
Transforming Cancer Care and Improving Patients’ Lives
In oncology, timely, accurate and comprehensive data is paramount to improving patient care and driving innovation in cancer treatment. Ontada is at the forefront of the rapidly changing field of oncology, providing near real-time data and insights directly from the community oncology setting, where 85% of cancer patients seek care.
We are an oncology technology and insights company founded on the core belief that precise insights — delivered exactly at the point of need — can save more patients’ lives.
Ontada is committed to reflecting the most current activity in the community oncology setting through our products and solutions. Our unique relationship with the country’s leading community oncology network, The US Oncology Network, means we deliver near real-time data, insights and research that reflects how cancer is treated in the community. Our embedded point-of-care solutions allow us to quickly adapt to new guidelines, biomarkers and treatments, and offer timely insights from the community.
Our Focus Areas
We help life sciences companies and community oncologists with:
Real-World Research
Provider Education and Engagement
Point-of-Care Solutions
Ontada at a Glance
Harnessing real-world evidence to improve patient care.
350+
We have supported more than 350 real-world research studies.
2.4M+
There are more than 2.4 million patient records available for research.
2.6k+
More than 2,600 oncology providers utilize our point of care solutions including our award winning electronic medical record, iKnowMed.
Discover Ontada News and Stories
McKesson Corporation Completes Acquisition of Core Ventures
McKesson’s Practice Insights Selected as a 2025 Qualified Clinical Data Registry by Centers for Medicare & Medicaid Services
Unlocking the Potential and Promise of Precision Medicine in Cancer Care
Ontada Collaborates with Datavant to Enable Faster Access to Market-Leading Oncology Insights
Ontada Collaborates with Microsoft to Transform Unstructured Oncology Data with Azure OpenAI Technology
VORANIGO (vorasidenib), FDA Approved for the Treatment of Patients with IDH-mutant Diffuse Glioma, Available at Biologics by McKesson
Learn More About McKesson’s Solutions
Oncology & Specialty Solutions
We help physicians take full advantage of patient data to make every clinical and operational choice with greater conviction, greater speed and greater connection to the best possible outcome.
Learn more about McKesson’s oncology and specialty solutions that are accelerating specialized care.
Biopharma Capabilities
We help life sciences companies accelerate oncology drug development and commercialization.
Learn more about McKesson’s biopharma capabilities that are advancing healthcare forward.